Acta Neuropathol (2010) 119:7–35 NC, Amara SG (2007) Enhancing glutamate transport: mecha- nism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom. Mol Pharmacol 72:1228–1237 71. Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, Lee VM, Trojanowski JQ (2005) Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 25:3539–3550 72. Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson’s disease. Prog Brain Res 94:429–436 73. Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR, Shaw PJ (1998) The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immu- nohistochemical study. Eur J Neurosci 10:2481–2489 74. Friedman A, Kaufer D, Heinemann U (2009) Blood-brain bar- rier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 85:142–149 75. Furer M, Hartloper V, Wilkins J, Nath A (1993) Lymphocyte emperipolesis in human glial cells. Cell Adhes Commun 1:223–237 76. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683– 2710 77. Gadea A, Schinelli S, Gallo V (2008) Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J Neurosci 28:2394–2408 78. Garcia ADR, Doan NB, Imura T, Bush TG, Sofroniew MV (2004) GFAP-expressing progenitors are the principle source of constitutive neurogenesis in adult mouse forebrain. Nature Neurosci 7:1233–1241 79. Garcia-Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray JM (2006) Pyruvate carbox- ylase deﬁciency: metabolic characteristics and new neurological aspects. Ann Neurol 59:121–127 80. Garcia-Segura LM, Melcangi RC (2006) Steroids and glial cell function. Glia 54:485–498 81. Ghatak NR (1992) Occurrence of oligodendrocytes within astrocytes in demyelinating lesions. J Neuropathol Exp Neurol 51:40–46 82. Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington’s disease. Eur J Neurosci 27:2803–2820 83. Goedert M, Jakes R (2005) Mutations causing neurodegenera- tive tauopathies. Biochim Biophys Acta 1739:240–250 84. Goldman S (2003) Glia as neural progenitor cells. Trends Neurosci 26:590–596 85. Goncalves CA, Leite MC, Nardin P (2008) Biological and methodological features of the measurement of S100B, a puta- tive marker of brain injury. Clin Biochem 41:755–763 86. Gordon GR, Mulligan SJ, MacVicar BA (2007) Astrocyte control of the cerebrovasculature. Glia 55:1214–1221 87. Gregorian C, Nakashima J, Dry SM, Nghiemphu PL, Smith KB, Ao Y, Dang J, Lawson G, Mellinghoff IK, Mischel PS, Phelps M, Parada LF, Liu X, Sofroniew MV, Eiber FC, Wu H (2009) PTEN dosage is essential for neuroﬁbroma development and malignant transformation. Proc Natl Acad Sci USA 106:19479–19484 88. Haberle J, Gorg B, Rutsch F, Schmidt E, Toutain A, Benoist JF, Gelot A, Suc AL, Hohne W, Schliess F, Haussinger D, Koch HG (2005) Congenital glutamine deﬁciency with glutamine syn- thetase mutations. N Engl J Med 353:1926–1933 89. Halassa MM, Fellin T, Haydon PG (2007) The tripartite syn- apse: roles for gliotransmission in health and disease. Trends Mol Med 13:54–63 90. Halassa MM, Fellin T, Haydon PG (2009) Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57:343–346 31 91. Halassa MM, Fellin T, Takano H, Dong JH, Haydon PG (2007) Synaptic islands deﬁned by the territory of a single astrocyte. J Neurosci 27:6473–6477 92. Hamby ME, Hewett JA, Hewett SJ (2006) TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. Glia 54:566–577 93. Haseloff RF, Blasig IE, Bauer HC, Bauer H (2005) In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol 25:25–39 94. Hernandez MR, Miao H, Lukas T (2008) Astrocytes in glau- comatous optic neuropathy. Prog Brain Res 173:353–373 95. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231–7243 96. Hewett JA (2009) Determinants of regional and local diversity within the astroglial lineage of the normal central nervous sys- tem. J Neurochem 110:1717–1736 97. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH (2000) Proliferation and differ- entiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20:2218–2228 98. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, Barbay JM, Marchant JK, Mahesh N, Porciatti V, Whitmore AV, Masland RH, John SW (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2 J glaucoma. J Cell Biol 179:1523–1537 99. Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS (2009) Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics 6:500–512 100. Hult B, Chana G, Masliah E, Everall I (2008) Neurobiology of HIV. Int Rev Psychiatry 20:3–13 101. Huynh DP, Vinters HV, Ho DH, Ho VV, Pulst SM (1997) Neuronal expression and intracellular localization of presenilins in normal and Alzheimer disease brains. J Neuropathol Exp Neurol 56:1009–1017 102. Iadecola C, Nedergaard M (2007) Glial regulation of the cere- bral microvasculature. Nat Neurosci 10:1369–1376 103. Imura T, Kornblum HI, Sofroniew MV (2003) The predominant neural stem cell isolated from postnatal and adult forebrain but not from early embryonic forebrain expresses GFAP. J Neurosci 23:2824–2832 104. Imura T, Nakano I, Kornblum HI, Sofroniew MV (2006) Phe- notypic and functional heterogeneity of GFAP-expressing cells in vitro: Differential expression of LeX/CD15 by GFAP- expressing multipotent neural stem cells and non-neurogenic astrocytes. Glia 53:277–293 105. Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ (2007) The role of the complement cascade in endotoxin- induced septic encephalopathy. Lab Invest 87:1186–1194 106. Jansen LA, Uhlmann EJ, Crino PB, Gutmann DH, Wong M (2005) Epileptogenesis and reduced inward rectiﬁer potassium current in tuberous sclerosis complex-1-deﬁcient astrocytes. Epilepsia 46:1871–1880 107. Jayakumar AR, Rama Rao KV, Tong XY, Norenberg MD (2009) Calcium in the mechanism of ammonia-induced astro- cyte swelling. J Neurochem 109(Suppl 1):252–257 108. John GR, Lee SC, Brosnan CF (2003) Cytokines: Powerful regulators of glial cell activation. Neuroscientist 9:10–22 109. Johnson EC, Morrison JC (2009) Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma 18:341–353 110. Kapur R, Donohue C, Jelinek D, Erickson RP (2009) Amelio- ration of enteric neuropathology in a mouse model of Niemann- Pick C by Npc1 expression in enteric glia. J Neurosci Res 87:2994–3001 123